3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
8
Terminated
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Conditions
Hyperuricemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myeloid, Acute
1
Congenital Abnormalities
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
rasburicase
2
Urate Oxidase
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Hyperuricemia
×
rasburicase
×
Clear all
NCT00607152
2014-05-08
Rasburicase (Fasturtec) Registration Trial
Sanofi
Phase 3
Terminated
10 enrolled
NCT00664144
2012-03-07
GRAAL2
Sanofi
Phase 2
Terminated
33 enrolled